Figure S1. Chemical inhibition of SHP1 and SHP2 favors the differentiation of HEL cells. Levels of CD41 and CD61 surface markers in HEL cells 48 h after 4h incubation with the indicated inhibitors of SHP1 and SHP2. Figure S2. Chemical inhibition of SHP1 and SHP2 potentiates morphological changes of PMA in HL-60 cells. Representative pictures of May-Grünwald-Giemsa stained cytospins of HL-60 cells after 48 h treatment with PRS, NSC and their combination. Scale bar: 10 μm. Figure S3. AML cell lines are differentially responsive to PRS and NSC. A) Dose-response curves of HL-60 cells treated with PRS and NSC during 48 h. B) Dose-response curves of AML cell lines different from HL-60 treated with PMA and NSC during 48 h. (DOCX 509 kb
Figure S1. The combination effect of MPT0G211 and chemotherapeutic agent on acute leukemia cell line...
Figure S4. (Arg)9-GST SH2 TrM inhibited the proliferation of A375/DDP cells. Effects of GST, GST SH2...
Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were t...
Table S1. Primary antibodies and working dilutions used for immunoblotting. Table S2. RNAi sequences...
Figure S4. Immortalized normal blood cells were resistant to ATRA. a Pin1 protein levels in two immo...
Figure S1. The original whole blots of Pin1 expression in AML patients and leukemia cell lines. a Th...
Figure S3. 1,25-(OH)2VitaminD3, does not affect Pin1 stability and function. a, b The expression of ...
Figure S1. Relative quantification of PTP4A3 (PRL-3) expression level in OCI-AML2 and MOLM-14 cells ...
Figure S1. The Effect of PCM on T Cells and Jurkat cells, Related to Fig. 1. Figure S2. ROS Scavenge...
Silencing SHP2 expression in the MDA-MB-231 (a) and MDA-MB-468 (b) cells drastically reduced EGFR pr...
(A/B) Ba/F3 vector cells and cells transformed with pBABE Bcr-Abl were exposed to the indicated inhi...
Dose response curve and chemoprotection of leukemia cells by MSC. a-c Dose response curve showing pe...
Additional file 1: Table S1. SHP1 shRNA sequence. Figure S1. P5C inhibits T cells cytokine productio...
Figure S2. MASTL depletion increases G2 arrest and the accumulation of pH 3. a The quantification of...
Effects of CHS-828 and chemotherapeutics on protein translation. A) Jurkat cells were treated for 48...
Figure S1. The combination effect of MPT0G211 and chemotherapeutic agent on acute leukemia cell line...
Figure S4. (Arg)9-GST SH2 TrM inhibited the proliferation of A375/DDP cells. Effects of GST, GST SH2...
Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were t...
Table S1. Primary antibodies and working dilutions used for immunoblotting. Table S2. RNAi sequences...
Figure S4. Immortalized normal blood cells were resistant to ATRA. a Pin1 protein levels in two immo...
Figure S1. The original whole blots of Pin1 expression in AML patients and leukemia cell lines. a Th...
Figure S3. 1,25-(OH)2VitaminD3, does not affect Pin1 stability and function. a, b The expression of ...
Figure S1. Relative quantification of PTP4A3 (PRL-3) expression level in OCI-AML2 and MOLM-14 cells ...
Figure S1. The Effect of PCM on T Cells and Jurkat cells, Related to Fig. 1. Figure S2. ROS Scavenge...
Silencing SHP2 expression in the MDA-MB-231 (a) and MDA-MB-468 (b) cells drastically reduced EGFR pr...
(A/B) Ba/F3 vector cells and cells transformed with pBABE Bcr-Abl were exposed to the indicated inhi...
Dose response curve and chemoprotection of leukemia cells by MSC. a-c Dose response curve showing pe...
Additional file 1: Table S1. SHP1 shRNA sequence. Figure S1. P5C inhibits T cells cytokine productio...
Figure S2. MASTL depletion increases G2 arrest and the accumulation of pH 3. a The quantification of...
Effects of CHS-828 and chemotherapeutics on protein translation. A) Jurkat cells were treated for 48...
Figure S1. The combination effect of MPT0G211 and chemotherapeutic agent on acute leukemia cell line...
Figure S4. (Arg)9-GST SH2 TrM inhibited the proliferation of A375/DDP cells. Effects of GST, GST SH2...
Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were t...